Skip to Content

797 (Divalproex Sodium Delayed-Release 250 mg)

Pill with imprint 797 is Orange, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 250 mg. It is supplied by Sun Pharmaceuticals.

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 797

Divalproex sodium delayed-release 250 mg 797
Divalproex sodium delayed-release 250 mg 797
Divalproex sodium delayed-release 250 mg 797 Front
Divalproex sodium delayed-release 250 mg 797 Back
Divalproex sodium delayed-release 250 mg 797

Divalproex Sodium Delayed-Release

Imprint
797
Strength
250 mg
Color
Orange
Size
15.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sun Pharmaceuticals
National Drug Code (NDC)
62756-0797
Inactive Ingredients
silicon dioxide, corn starch, povidone, hypromelloses, titanium dioxide, triacetin, methacrylic acid - ethyl acrylate copolymer (1:1) type a, triethyl citrate, sodium bicarbonate, sodium lauryl sulfate, FD&C Yellow No. 6, ferric oxide yellow, shellac, ferrosoferric oxide, butyl alcohol, propylene glycol, ammonia, magnesium silicate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "797"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.